IRTC
iRhythm Technologies·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 0
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About IRTC
Irhythm Technologies, Inc.
A leading digital health care company focused on creating trusted solutions that detect, prevent and predict disease
Healthcare Technology
09/14/2006
10/20/2016
NASDAQ Stock Exchange
2,000
12-31
Common stock
699 8th Street, Suite 600, San Francisco, California 94103
--
IRhythm Technologies, Inc., was incorporated in Delaware on September 14, 2006. The company is a commercial-grade digital healthcare company that redefines the way arrhythmia is diagnosed clinically through a combination of cloud-based data analysis and machine learning capabilities with wearable technology and biosensing. The company began commercializing its products in the United States in 2009 following a break from the U.S. Food and Drug Administration.
Earnings Call
Company Financials
EPS
IRTC has released its 2025 Q3 earnings. EPS was reported at 0.06, versus the expected -0.28, beating expectations. The chart below visualizes how IRTC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
IRTC has released its 2025 Q3 earnings report, with revenue of 192.88M, reflecting a YoY change of 30.74%, and net profit of -5.21M, showing a YoY change of 88.71%. The Sankey diagram below clearly presents IRTC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


